window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 20, 2026

  • News
  • About Us
Contact Us

synthetic biology

  • European biotech,Mental health,Neurosciences,Psychadelics

    Biotech and psychedelics converge: Psylink CEO Laura Korsakova on reshaping mental health at Baltic Life Sciences

    Speaking at Baltic Life Sciences, Laura Korsakova, co-founder and CEO [...]

    September 22, 2025
  • Clinical Development,Oncology,Partnerships & Funding,Precision medicine,Research & Development,RNA Therapeutics,Technology and platforms

    Strand lands $153M to advance programmable mRNA cancer therapies

    Boston-based Strand Therapeutics has raised $153 million in a Series [...]

    August 8, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Drug Development,Technology and platforms

    Elegen and Nutcracker pilot cell-free RNA manufacturing for personalized cancer therapeutics

    Collaboration targets faster, lower-cost production of RNA-based therapies with reduced [...]

    July 15, 2025
  • Cell & Gene Therapy,Partnerships & Funding,Technology and platforms

    Broken String and BioLizard partner on AI tool to improve gene editing safety

    Eurostars-3 grant supports development of SafeGuide to reduce time and [...]

    July 14, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Precision medicine,Technology and platforms

    Biostate AI raises $12M to build the ‘Netflix’ of molecular diagnostics using RNAseq and GenAI

    Biostate AI has raised $12 million in Series A funding [...]

    May 23, 2025
  • Cell & Gene Therapy

    GeneFab and RegCell partner to advance autoimmune Treg therapy toward US trials

    May 7, 2025
  • Biologics & Biosimilars,Drug Development

    Molecular Devices unveils automated QPix FLEX system to transform microbial colony picking

    New benchtop platform boosts speed, sterility, and accuracy for microbiology [...]

    May 7, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk
    Categories: Biotech, Clinical Development, Drug Development, European biotech, Hematology, Research & Development, Respiratory
  • SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform
    Categories: Data Management, Genomics and sequencing, Research & Development, Technology and platforms
  • Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema
    Categories: Clinical Trials, Dermatology, Drug Development, European biotech, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top